Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple‐negative breast cancerBeatriz E. Adrada, Gaiane M. Rauch, Rosalind P. Candelaria et al.|Cancer|2021Cited by 23
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)Abeer H. Abdelhafez, Gaiane M. Rauch, Benjamin C. Musall et al.|Breast Cancer Research and Treatment|2020Cited by 15
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in <scp>Triple‐Negative</scp> Breast CancerBenjamin C. Musall, Gaiane M. Rauch, Beatriz E. Adrada et al.|Journal of Magnetic Resonance Imaging|2022Cited by 13
83P Evaluation of concordance between PD-L1 immunohistochemistry 28-8 and 22C3 pharmDx assays in metastatic urothelial carcinoma (mUC) in PIVOT-10Arlene O. Siefker‐Radtke, Robert Huddart, David Chien et al.|Annals of Oncology|2021Cited by 0